Pharmacokinetic-Pharmacodynamic Modeling of Metformin for the Treatment of Type II Diabetes Mellitus
暂无分享,去创建一个
Bhushan Gopaluni | Ezra Kwok | Bhushan Gopaluni | E. Kwok | O. Vahidi | Omid Vahidi | Lin Sun | Lin Sun
[1] C. Cobelli,et al. Validation of mathematical models of complex endocrine-metabolic systems. A case study on a model of glucose regulation , 1983, Medical and Biological Engineering and Computing.
[2] J. H. Burke,et al. Portal blood flow in cirrhosis of the liver. , 1967, The Journal of clinical investigation.
[3] B. Ploeger,et al. Mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modeling in translational drug research. , 2008, Trends in pharmacological sciences.
[4] R. DeFronzo,et al. Metformin: A review of its metabolic effects , 1998 .
[5] D. Skaar,et al. Metformin, a Promising Oral Antihyperglycemic for the Treatment of Noninsulin‐Dependent Diabetes Mellitus , 1997, Pharmacotherapy.
[6] M. Ibbini,et al. A fuzzy logic based closed-loop control system for blood glucose level regulation in diabetics , 2005, Journal of medical engineering & technology.
[7] C. Bailey,et al. A Risk-Benefit Assessment of Metformin in Type 2 Diabetes Mellitus , 1999, Drug safety.
[8] E D Lehmann,et al. A physiological model of glucose-insulin interaction in type 1 diabetes mellitus. , 1992, Journal of biomedical engineering.
[9] Development of a physiological model forpatients with type 2 diabetes mellitus , 2010, Proceedings of the 2010 American Control Conference.
[10] V. Bolie,et al. Coefficients of normal blood glucose regulation. , 1961, Journal of applied physiology.
[11] C. Bailey,et al. Reconsideration of inhibitory effect of metformin on intestinal glucose absorption , 1991, The Journal of pharmacy and pharmacology.
[12] John Thomas Sorensen,et al. A physiologic model of glucose metabolism in man and its use to design and assess improved insulin therapies for diabetes , 1985 .
[13] P. Neuvonen,et al. Pharmacokinetics of metformin after intravenous and oral administration to man , 1979, European Journal of Clinical Pharmacology.
[14] K. Kwon,et al. Pharmacokinetic-pharmacodynamic modeling for the relationship between glucose-lowering effect and plasma concentration of metformin in volunteers , 2004, Archives of pharmacal research.
[15] I. Dicembrini,et al. A comparison of mealtime insulin aspart and human insulin in combination with metformin in type 2 diabetes patients. , 2007, Diabetes research and clinical practice.
[16] K. Johansen. Efficacy of metformin in the treatment of NIDDM. Meta-analysis. , 1999, Diabetes care.
[17] A. Hoffman,et al. Preclinical evaluation of pharmacokinetic-pharmacodynamic rationale for oral CR metformin formulation. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[18] MS Ibbini,et al. A semiclosed-loop optimal control system for blood glucose level in diabetics , 2004, Journal of medical engineering & technology.
[19] A. Hoffman,et al. Pharmacokinetic-pharmacodynamic analysis of the glucose-lowering effect of metformin in diabetic rats reveals first-pass pharmacodynamic effect. , 2002, Drug metabolism and disposition: the biological fate of chemicals.
[20] A Schumitzky,et al. A program package for simulation and parameter estimation in pharmacokinetic systems. , 1979, Computer programs in biomedicine.